What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Sylvia Wassertheil-Smoller spends much of her time researching Internal medicine, Women's Health Initiative, Stroke, Risk factor and Hazard ratio.
Her Internal medicine study combines topics from a wide range of disciplines, such as Placebo, Physical therapy, Surgery and Endocrinology.
Sylvia Wassertheil-Smoller interconnects Medroxyprogesterone acetate, Randomized controlled trial, Breast cancer, Hormone replacement therapy and Cohort in the investigation of issues within Women's Health Initiative.
Her Stroke research includes elements of Odds ratio, Diabetes mellitus, Blood pressure, Myocardial infarction and Hyperhomocysteinemia.
The Risk factor study combines topics in areas such as Body mass index, Relative risk, Prospective cohort study and Depression.
Her Hazard ratio research incorporates elements of Mortality rate and Diet therapy.
Her most cited work include:
- Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial (3739 citations)
- Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. (1731 citations)
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack (1121 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Women's Health Initiative, Stroke, Hazard ratio and Physical therapy.
In her study, Case-control study is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine.
The various areas that Sylvia Wassertheil-Smoller examines in her Women's Health Initiative study include Gerontology, Gynecology, Dementia, Breast cancer and Cohort.
Her Stroke study incorporates themes from Odds ratio, Myocardial infarction, Disease and Heart failure.
Her Hazard ratio research is multidisciplinary, incorporating elements of Quartile, Incidence, Cohort study and Obstetrics.
Her studies in Risk factor integrate themes in fields like Body mass index and Depression.
She most often published in these fields:
- Internal medicine (53.96%)
- Women's Health Initiative (32.93%)
- Stroke (17.99%)
What were the highlights of her more recent work (between 2014-2021)?
- Internal medicine (53.96%)
- Women's Health Initiative (32.93%)
- Prospective cohort study (14.94%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Internal medicine, Women's Health Initiative, Prospective cohort study, Cohort and Stroke.
Internal medicine is closely attributed to Oncology in her work.
The concepts of her Women's Health Initiative study are interwoven with issues in Cancer, Lower risk, Gerontology and Confounding.
Her work focuses on many connections between Prospective cohort study and other disciplines, such as Body mass index, that overlap with her field of interest in Risk factor, Endometrial cancer and Obesity.
Her research integrates issues of Odds ratio, Medical history, Heart failure, Blood pressure and Myocardial infarction in her study of Stroke.
Her research investigates the connection between Hazard ratio and topics such as Incidence that intersect with issues in Colorectal cancer.
Between 2014 and 2021, her most popular works were:
- Association of Cardiometabolic Multimorbidity With Mortality (289 citations)
- Genetic Diversity and Association Studies in US Hispanic/Latino Populations: Applications in the Hispanic Community Health Study/Study of Latinos (156 citations)
- Loci associated with ischaemic stroke and its subtypes (SiGN) : A genome-wide association study (144 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Internal medicine, Women's Health Initiative, Prospective cohort study, Hazard ratio and Cohort.
As part of her studies on Internal medicine, Sylvia Wassertheil-Smoller often connects relevant subjects like Oncology.
Her work carried out in the field of Women's Health Initiative brings together such families of science as Gerontology, Lower risk and Dementia, Disease, Cognitive decline.
The study incorporates disciplines such as Odds ratio, Endocrinology and Case-control study in addition to Prospective cohort study.
Her study looks at the relationship between Hazard ratio and fields such as Mortality rate, as well as how they intersect with chemical problems.
Her studies deal with areas such as Epidemiology, Rating scale, Diabetes mellitus, Center for Epidemiologic Studies Depression Scale and Stroke as well as Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
